Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Emerging Therapy Solutions
AddedFeb 15, 2024
UpdatedJun 18, 2026
Emerging Therapy Solutions

Emerging Therapy Solutions

Operating

ETS offers comprehensive healthcare solutions for high-cost therapies, specializing in cell, gene, and transplant therapies.

Location
Bloomington, MN, US
Founded
2018
Firm
Compare
Fundraising
Employees
Website

Emerging Therapy Solutions® (ETS) specializes in providing comprehensive healthcare solutions for high-cost therapies, with a focus on cell, gene, and transplant therapies. Founded in 2018, ETS primarily assists healthcare payers in managing the risks and costs associated with rare and complex medical conditions. The firm leverages its expertise to offer crucial insights, expert data analysis, and support to navigate the financial and logistical challenges of these advanced therapies.

ETS's notable acquisition of LifeTrac in 2020 expanded its capabilities by incorporating over 30 years of experience in bone marrow and solid organ transplants. This integration has strengthened ETS's provider relationships and agreements, enhancing its service offerings. Key partners and decision-makers at ETS are industry veterans from managed care solutions, healthcare biotech, and transplant sectors. The firm's investment philosophy centers on mitigating risks and ensuring preparedness for catastrophic claims, adding unique value to its portfolio companies through strategic planning and pricing guidance.

Emerging Therapy Solutions - Similar Investment Firms

Emerging Technology Partners logo

Emerging Technology Partners

Emerge logo

Emerge

emerge.me

Total Life logo

Total Life

totallife.com

EasyHealth logo

EasyHealth

joineasyhealth.com

xTeros logo

xTeros

xteros.com

Nomi Health logo

Nomi Health

nomihealth.com

InsurMedix logo

InsurMedix

insurmedix.com

Enter logo

Enter

enter.health

Trusty.care logo

Trusty.care

trusty.care

Gem Health logo

Gem Health

gem.health

HealthBridge logo

HealthBridge

myhealthbridge.com

EXtrance logo

EXtrance

Healthcare Highways logo

Healthcare Highways

Free Market Health logo

Free Market Health

NextWaveBio logo

NextWaveBio

Emerging Therapy Solutions - Classification

Also Known As
  • Emerging Therapy Solutions, Inc.
NAICS
  • 524000Insurance Carriers and Related Activities
  • 524100Insurance Carriers
  • 520000Finance and Insurance
SIC
  • 6300Insurance Carriers
Show 10 more industry codes
NAICS
  • 524110Direct Life, Health, and Medical Insurance Carriers
  • 524114Direct Health and Medical Insurance Carriers
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 6320Accident And Health Insurance And Medical Service Plans
  • 6321Accident And Health Insurance
  • 6000Depository Institutions
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified